COVID-19 in a child with primary antibody deficiency
- PMID: 33598240
- PMCID: PMC7869323
- DOI: 10.1002/ccr3.3643
COVID-19 in a child with primary antibody deficiency
Abstract
Although presentation of COVID-19 in patients with immunodeficiency could be mild, it should not be missed, while early diagnosis and appropriate treatment can survive infected patients. Because even severe infections in PID patients may be presented with few symptoms and signs, this diagnosis should be considered in those immunocompromised patients who have exacerbating preexisting symptoms.
Keywords: COVID‐19; SARS‐Cov2; primary antibody deficiency; primary immunodeficiency.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
None.
Figures
References
-
- Abolhassani H, Kiaee F, Tavakol M, et al. Fourth update on the Iranian national registry of primary immunodeficiencies: integration of molecular diagnosis. J Clin Immunol. 2018;38(7):816‐832. - PubMed
-
- Ahanchian H, Moazzen N, Joghatayi SH, et al. Death due to COVID‐19 in an Infant with combined immunodeficiencies. Endocr Metab Immune Disord Drug Targets. 2020. in press. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
